Comparing heparin and hirudin in hemodialysis
Treatments studied
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This trial compares two blood thinners (heparin vs. hirudin) used during hemodialysis to prevent clots. It is for people who have recently started dialysis (within the last 6 months) and are between 18 and 70 years old.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been on hemodialysis for less than 6 months.
- You agree to take part in the study.
- You do not have acute kidney injury (sudden kidney failure).
- You do not have a bleeding or clotting disorder.
- You do not have advanced liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to prevent blood clots during a specific type of kidney dialysis called hemodiafiltration. If you have end-stage kidney disease and receive dialysis three times a week, this study may help doctors find the safest anticoagulation method for you.
This study compares two dialysis membranes while using a reduced “weaning” plan for the blood thinner heparin during hemodialysis. It aims to see which membrane works better and safely during routine chronic dialysis.
This study tests whether dialysis can be done safely without using heparin (a blood thinner) in people with end-stage kidney disease. If successful, it could reduce the need for blood-thinning medications and their associated risks.
This trial tests whether giving heparin to patients in intensive care who have kidney problems can help prevent dangerous blood clots. Participants receive a standard dose or a dose adjusted for their kidney function. This could help protect patients who are at higher risk for clots due to their kidney condition.
This trial tests two blood thinners (nafamostat and heparin) during kidney dialysis for people with sepsis-related acute kidney injury. The goal is to find which is safer and works better.
This trial compares a newer type of dialysis called hemodiafiltration with standard hemodialysis to see if it improves certain health measures in people with end-stage kidney disease. It may help determine which method works better for long-term treatment.
Hear when a new Haemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.